Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Blueprint Medicines' fourth-quarter earnings and sales miss estimates. Shares of the company decline following the ...

Exelixis beats on Q4 earnings and sales as lead drug Cabometyx maintains momentum. The company reiterates its guidance for 2025.

Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

The Candy Basket Inc. recalled four of its products in California last month due to undeclared allergens, with the U.S. Food and Drug Administration now giving the situation a Class II or Class III ...

From that, the PRAC has concluded that the data “does not support a causal association” between the drugs and thyroid cancer ... and behaviour on their labels in the US and highlight the ...

Several imported fizzy drinks and sweets from America contain banned and illegal ingredients in the UK, according to the ...

Maintaining our health and well-being has never been more crucial in today’s fast-paced world. Unbalanced diets, constant ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...